Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome.
about
Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespanMediators of inflammation in polycystic ovary syndrome in relation to adiposityEffect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trialMetformin treatment before and during IVF or ICSI in women with polycystic ovary syndromeMetformin treatment before and during IVF or ICSI in women with polycystic ovary syndromeInsulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndromeDirect insulin and leptin action on pro-opiomelanocortin neurons is required for normal glucose homeostasis and fertilityImpact of treatment with rosiglitazone or metformin on biomarkers for insulin resistance and metabolic syndrome in patients with polycystic ovary syndromeThe management of infertility associated with polycystic ovary syndromePathophysiology, risk factors, and screening methods for prediabetes in women with polycystic ovary syndromeGenetic Rodent Models of Obesity-Associated Ovarian Dysfunction and Subfertility: Insights into Polycystic Ovary SyndromeRole of Anti-Müllerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: a reviewClinical characteristics in Taiwanese women with polycystic ovary syndromeReview of nonalcoholic fatty liver disease in women with polycystic ovary syndromeMetabolic disturbance in PCOS: clinical and molecular effects on skeletal muscle tissueEffect of metformin intervention during pregnancy on the gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and meta-analysisObesity and PCOS: implications for diagnosis and treatmentPolycystic Ovary Syndrome: Important Underrecognised Cardiometabolic Risk Factor in Reproductive-Age WomenEffects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled TrialsInositol Treatment and ART Outcomes in Women with PCOSThe menstrual cycle regularization following D-chiro-inositol treatment in PCOS women: a retrospective studyScreening for diabetes in pregnancyContributions of the Nurses' Health Studies to Reproductive Health ResearchScientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.Sleep Duration, Exercise, Shift Work and Polycystic Ovarian Syndrome-Related Outcomes in a Healthy Population: A Cross-Sectional StudyPancreatic β-cell dysfunction in polycystic ovary syndrome: role of hyperglycemia-induced nuclear factor-κB activation and systemic inflammation.Parent-of-origin effects on glucose homeostasis in polycystic ovary syndrome.Effects of hyperandrogenemia and increased adiposity on reproductive and metabolic parameters in young adult female monkeysAnti-Mullerian hormone may be a useful adjunct in the diagnosis of polycystic ovary syndrome in nonobese adolescents.Acupuncture for ovulation induction in polycystic ovary syndrome: a randomized controlled trial.Elevated androgens during puberty in female rhesus monkeys lead to increased neuronal drive to the reproductive axis: a possible component of polycystic ovary syndromeShould all women with PCOS be treated for insulin resistance?Assessment of insulin resistance and impaired glucose tolerance in lean women with polycystic ovary syndrome.The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome.Insulin sensitivity affects corticolimbic brain responses to visual food cues in polycystic ovary syndrome patients.Transcriptional profiling with a pathway-oriented analysis identifies dysregulated molecular phenotypes in the endometrium of patients with polycystic ovary syndrome.Simple modeling allows prediction of steady-state glucose disposal rate from early data in hyperinsulinemic glucose clamps.Large effects on body mass index and insulin resistance of fat mass and obesity associated gene (FTO) variants in patients with polycystic ovary syndrome (PCOS).Involvement of growth factors in the pathophysiology of polycystic ovary syndrome.Hyperandrogenism induces a proinflammatory TNFα response to glucose ingestion in a receptor-dependent fashion
P2860
Q21245262-D16FA2F9-E107-4A7D-8A52-FB0A72CC503EQ21296837-8CCC6E5D-5B44-4D00-A91A-A61FD343E67AQ22242102-B8EDF2E1-0468-4FCA-A6E6-8951848DD7ADQ24187959-6A9E28F7-FB4B-4999-AA70-9C43E2578412Q24241022-6B6AE049-77CC-487F-A813-3E59FAF5C58AQ24246323-D876DBF0-E816-4F56-BB74-E75C572D16C4Q24594995-E2A8E78C-5E50-468E-B6E1-EA905BECBDF2Q24646187-DA6B1D41-D56A-404D-945B-78B583C2CF14Q24798425-8C2DE46E-2CF8-422E-97DD-B391F635F142Q26738511-68090103-4D10-4EA5-901B-984BD46843E0Q26745164-DBA27858-CB10-4488-9B95-2D78D52724EBQ26774060-FB462F35-A46D-405A-836C-5A26C019E157Q26782559-77F72970-FB8B-48F7-B965-2D4C65239D7DQ26828765-E6CD1702-9072-4CCD-B18C-7B444AE112B1Q26830631-04E0AF6C-1209-4716-B344-0A60FA6ABEF2Q26991523-A6918021-6BDB-46CA-8167-A15940B45B37Q27000954-88A94E8D-CF19-472C-9319-154FFF808B59Q27021307-48EABA36-2A50-4181-9581-772BDDBA61A1Q28073603-1CD9C5FD-78A4-4C66-8320-2802A368498DQ28077261-FF86806E-93FD-4674-8C31-0C1A200C174EQ28248914-CD3C2FEA-195D-4093-911C-FE4AA16EC25FQ28360761-CB7C73AD-C50E-4322-864F-C448B9F2ADFEQ28386403-DC0E9D9C-CEBC-4A63-8960-E8AB06B4FCF0Q28390200-283499F7-178A-4385-B46D-76D522F7B034Q28917062-2D87B7F7-AEF4-42BA-97C4-2F9F54B131F1Q30359255-FC628E48-D913-43FB-9E62-86CCD373744EQ30371644-F91D165F-E8A2-4912-84EA-8DBF72D97E96Q30389395-6B9F918A-BD78-4500-9459-E1AEA77858CBQ30405604-B5773B22-1670-46AE-AEB1-E85838F7D702Q30411308-AB20C0DA-11DC-444D-AFCE-A2D21AA2962FQ30422591-AE3DC145-A3DB-4C78-8BD3-01D24B89DC99Q30423117-9CA0618E-A6B5-45AD-8999-5FA306C5DF3AQ30429162-9437D7A7-E5FC-4418-B61E-8215C7CFFC91Q30440354-2C283255-9C48-4797-923C-C335029F7B65Q31028805-0D56FB12-FF4F-4D11-8429-206D3DB90765Q33399651-EA98A02A-3556-4A84-9209-36CCC86FF4F6Q33516103-9D52DF7F-022E-4A43-9303-845959B6B70AQ33525709-C7DFDAC2-5C04-40AF-BA91-032FEA124DD4Q33538168-BF6FE58D-A562-49E4-946C-2BFE13301F37Q33569067-1938777F-79E2-4C25-8495-917841B56375
P2860
Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Profound peripheral insulin re ...... in polycystic ovary syndrome.
@en
Profound peripheral insulin re ...... in polycystic ovary syndrome.
@nl
type
label
Profound peripheral insulin re ...... in polycystic ovary syndrome.
@en
Profound peripheral insulin re ...... in polycystic ovary syndrome.
@nl
prefLabel
Profound peripheral insulin re ...... in polycystic ovary syndrome.
@en
Profound peripheral insulin re ...... in polycystic ovary syndrome.
@nl
P2093
P921
P356
P1433
P1476
Profound peripheral insulin re ...... in polycystic ovary syndrome.
@en
P2093
Dobrjansky A
Futterweit W
P304
P356
10.2337/DIAB.38.9.1165
P407
P577
1989-09-01T00:00:00Z